Academic Journal
Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape Analysis
| العنوان: | Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape Analysis |
|---|---|
| المؤلفون: | Graboyes, Evan M., Chappell, Michelle, Duckett, Kelsey A., Sterba, Katherine, Hughes Halbert, Chanita, Hill, Elizabeth G., Chera, Bhishamjit, McCay, Jessica, Puram, Sidharth V., Ramadan, Salma, Sandulache, Vlad C., Kahmke, Russel, Nussenbaum, Brian, Alberg, Anthony J., Paskett, Electra D., Calhoun, Elizabeth |
| المصدر: | Journal of the National Comprehensive Cancer Network ; volume 21, issue 12, page 1251-1259.e5 ; ISSN 1540-1405 1540-1413 |
| بيانات النشر: | Harborside Press, LLC |
| سنة النشر: | 2023 |
| الوصف: | Background: Aligned with the NCCN Clinical Practice Guidelines in Oncology for Head and Neck Cancers, in November 2021 the Commission on Cancer approved initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery for head and neck cancer (HNC) as its first and only HNC quality metric. Unfortunately, >50% of patients do not commence PORT within 6 weeks, and delays disproportionately burden racial and ethnic minority groups. Although patient navigation (PN) is a potential strategy to improve the delivery of timely, equitable, guideline-adherent PORT, the national landscape of PN for this aspect of care is unknown. Materials and Methods: From September through November 2022, we conducted a survey of health care organizations that participate in the American Cancer Society National Navigation Roundtable to understand the scope of PN for delivering timely, guideline-adherent PORT for patients with HNC. Results: Of the 94 institutions that completed the survey, 89.4% (n=84) reported that at least part of their practice was dedicated to navigating patients with HNC. Sixty-eight percent of the institutions who reported navigating patients with HNC along the continuum (56/83) reported helping them begin PORT. One-third of HNC navigators (32.5%; 27/83) reported tracking the metric for time-to-PORT at their facility. When estimating the timeframe in which the NCCN and Commission on Cancer guidelines recommend commencing PORT, 44.0% (37/84) of HNC navigators correctly stated ≤6 weeks; 71.4% (60/84) reported that they did not know the frequency of delays starting PORT among patients with HNC nationally, and 63.1% (53/84) did not know the frequency of delays at their institution. Conclusions: In this national landscape survey, we identified that PN is already widely used in clinical practice to help patients with HNC start timely, guideline-adherent PORT. To enhance and scale PN within this area and improve the quality and equity of HNC care delivery, organizations could focus on providing better ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| DOI: | 10.6004/jnccn.2023.7061 |
| الاتاحة: | http://dx.doi.org/10.6004/jnccn.2023.7061 https://jnccn.org/view/journals/jnccn/21/12/article-p1251.xml https://jnccn.org/downloadpdf/journals/jnccn/21/12/article-p1251.xml |
| رقم الانضمام: | edsbas.CD8B67D3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.6004/jnccn.2023.7061 |
|---|